ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,673.00
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,673.00 1,674.00 1,675.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.98 68.88B

AnaptysBio Says JEMPERLI Drug Gets FDA Approval

22/04/2021 10:19pm

Dow Jones News


Gsk (LSE:GSK)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Gsk Charts.

By Adriano Marchese

 

AnaptysBio Inc. said Thursday that the U.S. Food and Drug Administration approved GlaxoSmithKline PLC's biologics license application for JEMPERLI, a treatment for endometrial cancer.

The clinical-stage biotechnology company said JEMPERLI, also known as dostarlimab-gxly, was generated by AnaptysBio and developed by TESARO Inc.--now a part of GSK--under a collaboration agreement.

AnaptysBio received a $20 million milestone payment as part of the approval.

A Biologics License Application for JEMPERLI--a treatment for patients with mismatch repair deficient recurrent or advanced endometrial cancer--is needed to obtain permission for distribution across U.S. states.

"This event provides important validation for our proprietary SHM antibody discovery platform and provides significant potential future milestone and royalty revenue to support AnaptysBio's growth," President and Chief Executive Hamza Suria said.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

April 22, 2021 17:04 ET (21:04 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock